Immunotherapy and metastic renal cell cancer

Nephrol Dial Transplant. 1996 Sep;11(9):1890.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Carcinoma, Renal Cell / secondary
  • Carcinoma, Renal Cell / therapy*
  • Female
  • Humans
  • Immunotherapy* / adverse effects
  • Immunotherapy* / methods
  • Interferon Type I / administration & dosage
  • Interferon Type I / adverse effects
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / adverse effects
  • Kidney Neoplasms / therapy*
  • Male
  • Recombinant Proteins
  • Time Factors

Substances

  • Interferon Type I
  • Interleukin-2
  • Recombinant Proteins